Amneal Pharmaceuticals Inc Class A (AMRX)
EBITDA Margin
20.92%
TTM · Period ending:
AMRX EBITDA Margin
Latest reported20.92%period ending
Latest reported20.92%period ending
AMRX EBITDA Margin (30.97% → 20.92%)
Annual ebitda margin
High-resolution chart · PNG
AMRX ebitda margin history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| 20.004% | |
| 15.7401% | |
| 20.9216% | |
| 19.8982% | |
| 19.1576% | |
| 17.3451% | |
| 9.5426% | |
| -1.183% | |
| 26.2302% | |
| 30.1473% | |
| 29.1681% | |
| 30.967% |